danny i disagree. there are so many undervalued stocks out there right now. PDZ is a similar story, and a good year ahead of AAR, and they are only $25mill market cap.
TMR is a copper producer and is still at way less than 50% of its historical highs, and 30% of all broker recommendations.
ADY is less than half its highs too. the list goes on.
none of these companies are considered communication voids, like our own. the problem is wider, and once people feel like their money is safe in specs again, they will start buying.
in the meantime, the story looks prettier every day with global copper shortages helping the base metals along. 25% increase in prices this year all ready. we are entering the era everybody spoke about for years with regards the commodity super cycle, things are starting to get hot.
as soon as the market catches up, we are set to fly.
- Forums
- ASX - By Stock
- share price predictions
danny i disagree. there are so many undervalued stocks out there...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.5¢ |
Change
0.007(8.97%) |
Mkt cap ! $79.49M |
Open | High | Low | Value | Volume |
7.8¢ | 8.8¢ | 7.8¢ | $282.0K | 3.343M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 34320 | 8.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.5¢ | 331299 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 34320 | 0.083 |
1 | 100000 | 0.082 |
1 | 125000 | 0.080 |
2 | 150411 | 0.079 |
3 | 203805 | 0.076 |
Price($) | Vol. | No. |
---|---|---|
0.085 | 331299 | 2 |
0.088 | 6048 | 1 |
0.090 | 50000 | 1 |
0.091 | 20266 | 1 |
0.095 | 7200 | 1 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
FWD
Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
AAR (ASX) Chart |